Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Avoiding Cisplatin-Related Hearing Loss, Including Implementing Sodium Thiosulfate as Otoprotectant Into Daily Pediatric Clinical Practice: Proceedings Based on Evidence and Expert Opinion From the Ototoxicity Taskforce of the SIOP Supportive Care Network.

Ear and hearing·2026
Same author

The landscape of pediatric hepatocellular carcinoma and fibrolamellar carcinoma: A report from the Children's Hepatic tumors International Collaboration (CHIC).

Cancer·2026
Same author

A first-in-pediatric study of ALRN-6924, a novel stapled-peptide dual MDM2/MDMX inhibitor, for children with advanced hematologic and solid malignancies.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Local application of otoprotective compounds other than sodium thiosulfate to prevent cisplatin-induced hearing loss: a systematic review.

Drug delivery·2026
Same author

Clinical guideline for the diagnosis and treatment of fibrolamellar carcinoma.

Hepatology (Baltimore, Md.)·2026
Same author

Global Re-Analysis Confirms Absence of the <i>DNAJB1</i>::<i>PRKACA</i> Fusion in Hepatoblastoma. Comment on Fleifil et al. DNAJB1-PKAc Kinase Is Expressed in Young Patients with Pediatric Liver Cancers and Enhances Carcinogenic Pathways. <i>Cancers</i> 2025, <i>17</i>, 83.

Cancers·2026

Related Experiment Video

Updated: Mar 7, 2026

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy
04:41

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Published on: March 10, 2023

1.7K

Unresectable hepatoblastoma: current perspectives.

Angela D Trobaugh-Lotrario1, Rebecka L Meyers2, Allison F O'Neill3

  • 1Department of Pediatric Hematology and Oncology, Providence Sacred Heart Children's Hospital, Spokane, WA.

Hepatic Medicine : Evidence and Research
|February 17, 2017
PubMed
Summary

Hepatoblastoma, a rare pediatric liver tumor, often requires neoadjuvant chemotherapy for resection. Interventional techniques offer a promising alternative for unresectable cases, potentially avoiding liver transplantation.

Keywords:
hepatoblastomapediatricunresectable

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.3K
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.6K

Related Experiment Videos

Last Updated: Mar 7, 2026

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy
04:41

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Published on: March 10, 2023

1.7K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.3K
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.6K

Area of Science:

  • Pediatric Oncology
  • Hepatobiliary Surgery
  • Interventional Radiology

Background:

  • Hepatoblastoma is the most common primary liver tumor in children.
  • Complete surgical resection is essential for curative treatment.
  • Many patients present with unresectable tumors at diagnosis.

Purpose of the Study:

  • To explore the role of interventional techniques in managing unresectable hepatoblastoma.
  • To evaluate the potential of these techniques to facilitate tumor resection.
  • To assess if interventional methods can reduce the need for liver transplantation.

Main Methods:

  • Review of current treatment paradigms for hepatoblastoma.
  • Analysis of neoadjuvant chemotherapy's role in rendering tumors resectable.
  • Exploration of interventional techniques as salvage therapy for chemotherapy-resistant tumors.

Main Results:

  • Neoadjuvant chemotherapy improves resectability in most pediatric liver cancer cases.
  • Interventional techniques show promise for reducing tumor burden in unresectable hepatoblastoma.
  • These methods may decrease systemic toxicity and the need for liver transplantation.

Conclusions:

  • Interventional techniques represent a viable option for hepatoblastoma patients with unresectable tumors post-chemotherapy.
  • Successful application of these techniques can increase tumor resection feasibility.
  • Further research into interventional strategies may optimize outcomes and reduce reliance on liver transplantation.